Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning

Benzer Materyaller

• Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome
  Yazar:: Choi, Mihong, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
  Yazar:: Byun, Ja Min, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin
  Yazar:: Baron, Frédéric, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors
  Yazar:: Grunwald, Michael R., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Anti-thymocyte Globulin plus Etanercept as Therapy for Myelodysplastic Syndromes (MDS): a Phase II Study
  Yazar:: Scott, Bart L., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)